Norgine, Applied Pharma Research sales and marketing update

Applied Pharma Research granted Norgine commercialization rights to Setofilm ondansetron in Europe and certain countries in the Middle East, Africa, and Australasia. Setofilm is a dissolving oral film strip formulation of ondansetron using RapidFilm technology that is approved in 16 European countries to treat and prevent chemotherapy- and radiation-induced nausea and vomiting and post-operative nausea and vomiting (PONV). Terms were not disclosed. ...